Bionano Genomics (BNGO) Receivables - Other (2021 - 2025)

Bionano Genomics has disclosed Receivables - Other across 5 years of filings, most recently posting $12000.0 for Q4 2025.

• Receivables - Other for Q4 2025 came in at $12000.0, down 96.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $12000.0 (down 96.0% YoY), and the FY2025 annual result was $12000.0, down 96.0% from the prior year.
• Receivables - Other came in at $12000.0 for Q4 2025 at Bionano Genomics, down from $300000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $474000.0 in Q4 2022 to a low of $12000.0 in Q4 2025.
• The 5-year median for Receivables - Other is $342000.0 (2023), against an average of $303000.0.
• Across the five-year window, Receivables - Other gained 22.48% in 2022 and slumped 96.0% in 2025, its largest moves.
• Bionano Genomics' Receivables - Other stood at $387000.0 in 2021, then advanced by 22.48% to $474000.0 in 2022, then declined by 27.85% to $342000.0 in 2023, then slipped by 12.28% to $300000.0 in 2024, then plunged by 96.0% to $12000.0 in 2025.
• The last three Receivables - Other figures came in at $12000.0 (Q4 2025), $300000.0 (Q4 2024), and $342000.0 (Q4 2023), per Business Quant data.